Patents by Inventor Daniel L. Kisner

Daniel L. Kisner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition and method for treatment of CMV infections
    Patent number: 6153595
    Abstract: This invention concerns compositions and methods for the treatment of CMV infections. Antisense oligonucleotides are provided which are effective antiviral agents. In preferred embodiments, the oligonucleotides contain at least one 2'-methoxyethoxy modification and may be chimeric oligonucleotides.
    Type: Grant
    Filed: April 9, 1997
    Date of Patent: November 28, 2000
    Assignee: Isis Pharmaceuticals Inc.
    Inventors: Kenneth G. Draper, Daniel L. Kisner, Kevin P. Anderson, Sharon Chapman
  • Antisense composition and method for treatment of CMV infection
    Patent number: 5767102
    Abstract: This invention concerns compositions and methods for the treatment of CMV infections. A composition including an antisense oligonucleotide targeted to the IE2 gene of CMV and a pharmaceutically acceptable carrier were used stop progression in CMV retinitis.
    Type: Grant
    Filed: January 17, 1997
    Date of Patent: June 16, 1998
    Assignee: Isis Pharmaceuticals, Inc.
    Inventors: Kenneth G. Draper, Sharon K. Chapman, Daniel L. Kisner
  • Composition and method for treatment of CMV retinites
    Patent number: 5595978
    Abstract: This invention concerns compositions and methods for the treatment of CMV infections. A composition including an antisense oligonucleotide targeted to the IE2 gene of CMV and a pharmaceutically acceptable carrier were used stop progression in CMV retinitis.
    Type: Grant
    Filed: April 26, 1994
    Date of Patent: January 21, 1997
    Assignee: Isis Pharmaceuticals, Inc.
    Inventors: Kenneth G. Draper, Sharon K. Chapman, Daniel L. Kisner